|
|
||||||||
To define an effective and deliverable antimalarial regimen for use during pregnancy, pregnant women at highest risk of malaria (those in their first or second pregnancy) in an area of Malawi with high transmission of chloroquine (CQ)-resistant Plasmodium falciparum were placed on CQ and/or sulfadoxine-pyrimethamine (SP). Of 38 pregnant women who received CQ treatment followed by weekly CQ prophylaxis (CQ/CQ) for at least 45 days prior to delivery, 32% had placental malaria infection, compared with 26% of 50 pregnant women who received a treatment dose of SP followed by weekly CQ prophylaxis (SP/CQ), and only 9% of 71 pregnant women who received a two-dose SP regimen (SP/SP; given once during the second trimester and repeated at the beginning of the third trimester) (P = 0.006, by chi-square test). During the peak transmission season from April to July, 47% of the women who received CQ/CQ had placental malaria infection at delivery, as compared with 37% of the women who received SP/CQ, and 10% of women who received SP/SP (P = 0.004, by chi-square test). Among women in their first or second pregnancy, two treatment doses of SP were highly effective in decreasing the proportion of women with placental malaria infection at delivery.
This article has been cited by other articles:
![]() |
S. J. Rogerson, V. Mwapasa, and S. R. Meshnick Malaria in Pregnancy: Linking Immunity and Pathogenesis to Prevention Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 14 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramharter, K. Schuster, M. K. Bouyou-Akotet, A. A. Adegnika, K. Schmits, G. Mombo-Ngoma, S. T. Agnandji, J. Nemeth, S. N. Afene, S. Issifou, et al. Malaria in Pregnancy Before and After the Implementation of a National IPTp Program in Gabon Am J Trop Med Hyg, September 1, 2007; 77(3): 418 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. O. ter Kuile, A. M. van Eijk, and S. J. Filler Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During Pregnancy: A Systematic Review JAMA, June 20, 2007; 297(23): 2603 - 2616. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. TUKUR, T. D. THACHER, A. S. SAGAY, and J. K. A. MADAKI A COMPARISON OF SULFADOXINE-PYRIMETHAMINE WITH CHLOROQUINE AND PYRIMETHAMINE FOR PREVENTION OF MALARIA IN PREGNANT NIGERIAN WOMEN Am J Trop Med Hyg, June 1, 2007; 76(6): 1019 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. SIRIMA, A. H. COTTE, A. KONATE, A. C. MORAN, K. ASAMOA, E. C. BOUGOUMA, A. DIARRA, A. OUEDRAOGO, M. E. PARISE, and R. D. NEWMAN MALARIA PREVENTION DURING PREGNANCY: ASSESSING THE DISEASE BURDEN ONE YEAR AFTER IMPLEMENTING A PROGRAM OF INTERMITTENT PREVENTIVE TREATMENT IN KOUPELA DISTRICT, BURKINA FASO. Am J Trop Med Hyg, August 1, 2006; 75(2): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MBAYE, K. RICHARDSON, B. BALAJO, S. DUNYO, C. SHULMAN, P. MILLIGAN, B. GREENWOOD, and G. WALRAVEN LACK OF INHIBITION OF THE ANTI-MALARIAL ACTION OF SULFADOXINE-PYRIMETHAMINE BY FOLIC ACID SUPPLEMENTATION WHEN USED FOR INTERMITTENT PREVENTIVE TREATMENT IN GAMBIAN PRIMIGRAVIDAE Am J Trop Med Hyg, June 1, 2006; 74(6): 960 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Cot and P Deloron Malaria prevention strategies: Pregnancy-Associated Malaria (PAM) Br. Med. Bull., December 1, 2003; 67(1): 137 - 148. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |